C. Saunders

Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.

L. Stamatatos, Z. Kraft, I. Srivastava, 2006, Virology.

Age-Associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade

F. Hollfelder, M. MacFarlane, Md. Zulfekar Ali, 2022, medRxiv.

Macaques Infected with a CCR5-Tropic Simian/Human Immunodeficiency Virus (SHIV) Develop Broadly Reactive Anti-HIV Neutralizing Antibodies

N. Haigwood, L. Stamatatos, T. Wrin, 2007, Journal of Virology.

The V1, V2, and V3 Regions of the Human Immunodeficiency Virus Type 1 Envelope Differentially Affect the Viral Phenotype in an Isolate-Dependent Manner

L. Stamatatos, C. Cheng‐Mayer, Z. Kraft, 2005, Journal of Virology.

N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies

L. Stamatatos, M. Hensel, Ruth A McCaffrey, 2004, Journal of Virology.

Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV.

L. Stamatatos, A. Gettie, J. Blanchard, 2004, Virology.